Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a physician concerning a 21 week old male who on an unknown date and on 20-MAR-2007 was vaccinated PO with his first and second 2.0 ml doses of Rotateq. On approximately 07-APR-2007 per the physician, "the patient was brought into the office at 5 months old and was lethargic." On 27-APR-2007 the patient diagnosed with intussusception and was hospitalized (amount of time unknown). Surgery was performed and the patient had a necrotic bowel therefore the bowel had to be resected. The patient returned to the office for a follow-up visit and the third dose of Rotateq was administered by a different provider in the office. Subsequently, the patient recovered. There was no product quality complaint. Intussusception was also considered to be an other important medical event (surgery) by the physician. Additional information has been requested. 4/22/08-record received-Surgical report 4/29/07-Intussusception, ileocolic and ilioiliac due to mesenteric adenitis and possible hypertrophic tire patches, terminal ileum. Exploratory laparotomy with reduction of ileocolic anastomosis and small bowel resection. Seen in ER with 3 day history of URI like symptoms. Lethargic after receiving anti-histamine. Nausea and vomiting. Diminished appetite and urine output. Low grade temperature. Weight loss. Dehydration. Drowsiness secondary to possible antihistamine overdose.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166